CN104946755A - Brca1蛋白在制备逆转肿瘤细胞对mtx耐药性的药物中的应用 - Google Patents
Brca1蛋白在制备逆转肿瘤细胞对mtx耐药性的药物中的应用 Download PDFInfo
- Publication number
- CN104946755A CN104946755A CN201510319265.2A CN201510319265A CN104946755A CN 104946755 A CN104946755 A CN 104946755A CN 201510319265 A CN201510319265 A CN 201510319265A CN 104946755 A CN104946755 A CN 104946755A
- Authority
- CN
- China
- Prior art keywords
- cell
- brca1
- mtx
- dms
- dhfr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6841—In situ hybridisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/906—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7)
- G01N2333/9065—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on CH-NH groups of donors (1.5)
- G01N2333/90655—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on CH-NH groups of donors (1.5) with NAD or NADP as acceptor (1.5.1) in general
- G01N2333/90661—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on CH-NH groups of donors (1.5) with NAD or NADP as acceptor (1.5.1) in general with a definite EC number (1.5.1.-)
- G01N2333/90666—Dihydrofolate reductase [DHFR] (1.5.1.3)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510319265.2A CN104946755B (zh) | 2015-06-11 | 2015-06-11 | Brca1蛋白在制备逆转肿瘤细胞对mtx耐药性的药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510319265.2A CN104946755B (zh) | 2015-06-11 | 2015-06-11 | Brca1蛋白在制备逆转肿瘤细胞对mtx耐药性的药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104946755A true CN104946755A (zh) | 2015-09-30 |
CN104946755B CN104946755B (zh) | 2017-07-11 |
Family
ID=54161817
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510319265.2A Active CN104946755B (zh) | 2015-06-11 | 2015-06-11 | Brca1蛋白在制备逆转肿瘤细胞对mtx耐药性的药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104946755B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106492217A (zh) * | 2016-10-31 | 2017-03-15 | 哈尔滨医科大学 | Parp1抑制剂在制备逆转肿瘤细胞对氨甲蝶呤耐药性药物中的应用 |
CN109200288A (zh) * | 2018-09-14 | 2019-01-15 | 哈尔滨医科大学 | Msh3蛋白抑制剂在制备逆转mtx耐药肿瘤细胞耐药性的药物中的应用 |
CN109289051A (zh) * | 2018-09-14 | 2019-02-01 | 哈尔滨医科大学 | Msh2抑制剂在制备逆转mtx耐药肿瘤细胞耐药性的药物中的应用 |
CN110408696A (zh) * | 2019-04-29 | 2019-11-05 | 南昌大学第二附属医院 | Rock2在制备治疗逆转骨肉瘤细胞对trail耐药药物中的应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103301447A (zh) * | 2013-06-25 | 2013-09-18 | 哈尔滨医科大学 | DNA-PKcs在制备改变肿瘤细胞对MTX耐药性的药物中的应用 |
-
2015
- 2015-06-11 CN CN201510319265.2A patent/CN104946755B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103301447A (zh) * | 2013-06-25 | 2013-09-18 | 哈尔滨医科大学 | DNA-PKcs在制备改变肿瘤细胞对MTX耐药性的药物中的应用 |
Non-Patent Citations (4)
Title |
---|
AMREEN HUSAIN: "BRCA1 Up-Regulation Is Associated with Repair-mediated Resistance to cis-Diamminedichloroplatinum", 《CANCER RESEARCH》 * |
RUIZ-HERRERA等: "Gene amplification in human cells knocked down for RAD54", 《GENOME INTEGRITY》 * |
XIANGNING MENG: "Novel role for non-homologous end joining in the formation of double minutes in methotrexate-resistant colon cancer cells", 《JOURNAL OF MEDICAL GENETICS》 * |
刘璐: "BRCA1/2基因与Eμ-Myc p19Arf-/-细胞药物敏感性及其表达在乳腺癌中的临床意义", 《中国博士学位论文全文数据库 医药卫生科技辑》 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106492217A (zh) * | 2016-10-31 | 2017-03-15 | 哈尔滨医科大学 | Parp1抑制剂在制备逆转肿瘤细胞对氨甲蝶呤耐药性药物中的应用 |
CN106492217B (zh) * | 2016-10-31 | 2018-12-28 | 哈尔滨医科大学 | Parp1抑制剂在制备逆转肿瘤细胞对氨甲蝶呤耐药性药物中的应用 |
CN109200288A (zh) * | 2018-09-14 | 2019-01-15 | 哈尔滨医科大学 | Msh3蛋白抑制剂在制备逆转mtx耐药肿瘤细胞耐药性的药物中的应用 |
CN109289051A (zh) * | 2018-09-14 | 2019-02-01 | 哈尔滨医科大学 | Msh2抑制剂在制备逆转mtx耐药肿瘤细胞耐药性的药物中的应用 |
CN109289051B (zh) * | 2018-09-14 | 2021-01-08 | 哈尔滨医科大学 | Msh2抑制剂在制备逆转mtx耐药肿瘤细胞耐药性的药物中的应用 |
CN109200288B (zh) * | 2018-09-14 | 2021-05-18 | 哈尔滨医科大学 | Msh3蛋白抑制剂在制备逆转mtx耐药肿瘤细胞耐药性的药物中的应用 |
CN110408696A (zh) * | 2019-04-29 | 2019-11-05 | 南昌大学第二附属医院 | Rock2在制备治疗逆转骨肉瘤细胞对trail耐药药物中的应用 |
CN110408696B (zh) * | 2019-04-29 | 2023-05-16 | 南昌大学第二附属医院 | Rock2在制备治疗逆转骨肉瘤细胞对trail耐药药物中的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN104946755B (zh) | 2017-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Liang et al. | Exosomal microRNA-144 from bone marrow-derived mesenchymal stem cells inhibits the progression of non-small cell lung cancer by targeting CCNE1 and CCNE2 | |
CN103301447B (zh) | DNA-PKcs在制备改变肿瘤细胞对MTX耐药性的药物中的应用 | |
CN104946755A (zh) | Brca1蛋白在制备逆转肿瘤细胞对mtx耐药性的药物中的应用 | |
CN111979290B (zh) | Spp1基因在制备增强卵巢癌患者对parp抑制剂敏感性的药物中的应用 | |
CN110129447A (zh) | Pqbp1在卵巢癌诊治中的应用 | |
CN106492217B (zh) | Parp1抑制剂在制备逆转肿瘤细胞对氨甲蝶呤耐药性药物中的应用 | |
CN105435228A (zh) | 三氧化二砷的抗肿瘤新用途及抗肿瘤制剂 | |
Liu et al. | MicroRNA155 in the growth and invasion of salivary adenoid cystic carcinoma | |
CN109468382A (zh) | lncRNA在肺腺癌诊疗中的应用 | |
CN106434864A (zh) | 肿瘤标志物limk1及其应用 | |
CN109825587B (zh) | 一种胶质瘤预后标志物cpvl及其应用 | |
Zhang et al. | Tumor-derived exosomal lincRNA ROR promotes angiogenesis in nasopharyngeal carcinoma | |
CN103920164B (zh) | MiR-424-5p在抑制转移性肝癌中的应用 | |
CN113908283A (zh) | Prmt5抑制剂及其与pd-l1抗体阻断剂联合在治疗肺癌上的应用 | |
CN102168085A (zh) | 抑制miR-130b基因表达的siRNA和表达载体及其在制备提高肝癌治疗效果的药物中的应用 | |
CN108660212B (zh) | Wdr1基因在制备非小细胞肺癌治疗和检测产品中的应用 | |
Xia et al. | Up-regulation of MARVEL domain-containing protein 1 (MARVELD1) accelerated the malignant phenotype of glioma cancer cells via mediating JAK/STAT signaling pathway | |
CN102391372B (zh) | 一种肝癌药物治疗的靶标及其应用 | |
CN109929844B (zh) | 一种胶质瘤预后标志物cpvl抑制剂及其应用 | |
CN108034719A (zh) | Gins4基因或gins4蛋白作为生物标志物在制备肺腺癌的预诊断试剂中的应用 | |
CN106282385A (zh) | 长链非编码rna xloc_000090在肺癌中的鉴定和用途 | |
CN103205400B (zh) | 含有人泛素特异性蛋白酶基因USP39-shRNA的重组慢病毒及其应用 | |
CN102031308A (zh) | miRNA-29a化合物作为脑胶质瘤标志物的应用 | |
CN110433171A (zh) | miRNA-1293在制备抗结直肠肿瘤药物中的应用 | |
Zhang et al. | miR‐657 Targets SRCIN1 via the Slug Pathway to Promote NSCLC Tumor Growth and EMT Induction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Meng Xiangning Inventor after: Ma Jinfa Inventor after: Cai Mengdi Inventor after: Li Chunxiang Inventor after: Zhu Jing Inventor after: Liu Peng Inventor after: Gao Wei Inventor after: Guan Rongwei Inventor after: Hou Liqing Inventor after: Zhang Huishu Inventor before: Meng Xiangning Inventor before: Cai Mengdi Inventor before: Li Chunxiang Inventor before: Zhu Jing Inventor before: Liu Peng Inventor before: Gao Wei Inventor before: Guan Rongwei Inventor before: Hou Liqing |